Related Experiment Video
Updated: Feb 24, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Non-aneurysmal Subarachnoid Hemorrhage in an Adult With Sickle Cell Anemia: A Case Report and Review of the
Fahad M Okal1, Tala AlSindi2, Naif F AlHarbi3
1Neurosurgery, King Abdulaziz Medical City, Jeddah, SAU.
Abstract:
Moyamoya disease (MMD) is a rare, idiopathic cerebrovascular disorder characterized by bilateral stenosis of the internal carotid arteries (ICAs) and the formation of collateral vessels at the base of the brain. In patients with sickle cell disease (SCD), chronic vaso-occlusive changes can produce moyamoya-like vasculopathy, resulting in moyamoya syndrome (MMS) and increasing the risk of aneurysm formation and rupture. Nonetheless, presentation of MMS as non-aneurysmal subarachnoid hemorrhage (NASAH) is extremely rare, with few reported cases. Our case is about a 28-year-old male, a known case of SCD, who developed NASAH. He presented with a sudden decrease in consciousness, severe headache, nausea, and vomiting. Emergency evaluation revealed significant neurological impairment. Unenhanced brain computed tomographic imaging showed pure intraventricular hemorrhage. Computed tomographic angiography revealed the absence of contrast filling in both ICAs at the level of bifurcation, with prominent posterior circulation. Suspicion of MMS was raised. Diagnostic cerebral angiography revealed a complete absence of the right ICA and an almost completely occluded left ICA terminating at the anterior communicating artery (Acom). A run-through vertebral artery injection revealed the classic "puff of smoke" appearance, confirming the diagnosis of MMS. The patient was managed conservatively with the SAH protocol and was admitted to the intensive care unit. The patient passed away after a complicated course with multiple stroke events. MMD presenting as NASAH is uncommon and is believed to result from rupture of fragile vessels associated with MMD. This case supports previous findings, highlighting the importance of recognizing this presentation for timely management.
Insights
Moyamoya syndrome (MMS), a rare complication of sickle cell disease (SCD), can present as non-aneurysmal subarachnoid hemorrhage (NASAH). This case highlights the critical need to recognize this rare presentation for prompt management.
Area of Science:
- Neurology
- Vascular Neurology
- Genetics
Background:
- Moyamoya disease (MMD) involves internal carotid artery stenosis and collateral vessel formation.
- Sickle cell disease (SCD) can cause moyamoya-like changes, termed moyamoya syndrome (MMS).
- MMS presenting as non-aneurysmal subarachnoid hemorrhage (NASAH) is exceptionally rare.
More Related Videos
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies

